The US Food and Drug Administration has posted a warning letter to Indian drugmaker Torrent Pharmaceuticals. To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology

The US health regulator has red flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP) regulations at its Indrad facility in Gujarat. The United States Food and Drug Administration had inspected the facility from April 8 to 16, 2019.In a warning letter issued by the regulator to Torrent Pharma's CEO Samir Mehta, the regulator said, "Your firm Hi, Yesterday I received an email from my ISP warning me to stop violating copyrights and prevent from such activities, I usually download files using torrent. I assured them and stopped torrenting for now. But I feel stripped off of my privacy, and I am concerned about my Torrenting. Is there an Learn about the types of warning letters on FDA's website. Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may FDA sent a warning letter, dated Oct. 28, 2019, to Torrent Pharma after an inspection of the company's Levittown, PA facility found deviations from current good manufacturing practices.During the inspection, which was conducted from March 11-April 9, 2019, FDA investigators found that the company's water system was inadequate, and it had failed to properly investigate failing NEW DELHI: The US Food and Drug Administration (FDA) issued a warning letter to Torrent Pharmaceuticals Ltd's Indrad plant in Gujarat on Tuesday following an inspection of the facility in April

Torrent Pharmaceuticals has acquired Bio-Pharm, a generic and overthe-counter drugmaker based in Levittown, Pennsylvania, for an undisclosed sum. "This acquisition is an important step for increasing Torrent's presence in the United States, is consistent with our strategy of dosage form diversification, and provides us with new capabilities including manufacturing and R&D presence in the

The so-called six-strikes anti-piracy scheme in the United States may be dead but file-sharers should be aware that they're still being monitored. Over the past several weeks there have been Thank you very much for your solid explanations. Can you clarify if Comcast actually monitors all of their customer's Internet activities and then Comcast sends a DMCA take down to the customer or CD Projekt RED monitors the Witcher 3: Wild Hunt Game of the Year Edition torrent file on The Pirate Bay

This could potentially be a letter but it's more likely to arrive in the form of an email, delivered to the account registered with the ISP. Read the warning notice - and now read it again

The US health regulator has red flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP) regulations at its Indrad facility in Gujarat. The United States Food and Drug Administration had inspected the facility from April 8 to 16, 2019.In a warning letter issued by the regulator to Torrent Pharma's CEO Samir Mehta, the regulator said, "Your firm Hi, Yesterday I received an email from my ISP warning me to stop violating copyrights and prevent from such activities, I usually download files using torrent. I assured them and stopped torrenting for now. But I feel stripped off of my privacy, and I am concerned about my Torrenting. Is there an Learn about the types of warning letters on FDA's website. Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may FDA sent a warning letter, dated Oct. 28, 2019, to Torrent Pharma after an inspection of the company's Levittown, PA facility found deviations from current good manufacturing practices.During the inspection, which was conducted from March 11-April 9, 2019, FDA investigators found that the company's water system was inadequate, and it had failed to properly investigate failing NEW DELHI: The US Food and Drug Administration (FDA) issued a warning letter to Torrent Pharmaceuticals Ltd's Indrad plant in Gujarat on Tuesday following an inspection of the facility in April Warning Letters 2018. These letters are supplied by the CDER Freedom of Electronic Information Office. This page only covers Office of Prescription Drug Promotion (formerly Division of Drug